Navigation Links
Umbilical cord blood cell transplants may help ALS patients
Date:6/24/2008

Tampa, FL (June 24, 2008) A study at the University of South Florida has shown that transplants of mononuclear human umbilical cord blood (MNChUCB) cells may help patients suffering from Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. A disease in which the motor neurons in the spinal cord and brain degenerate, ALS leaves its victims with progressive muscle weakness, paralysis and, finally, respiratory failure three to five years after diagnosis.

In this study, USF researchers transplanted human umbilical cord blood (HUCB) cells into mouse models with ALS. Cells were transplanted at three different dose strength levels -- low, moderate and high -- to determine the degree to which dose levels of transplanted cells might delay disease symptom progression and increase lifespan. In results published today online at PloS ONE (Public Library of Science), researchers determined that the moderate-strength dose of HUCB cells was most effective in increasing lifespan and reducing disease progression.

"Our results demonstrate that treatment for ALS with an appropriate dose of MNC hUBC cells may provide a neuroprotective effect for motor neurons through active involvement of these cells in modulating the host immune inflammatory system response," said the study's lead author Svitlana Garbuzova-Davis, PhD, DSc, of the Center of Excellence for Aging and Brain Repair at USF.

According to the research team, modulating immune and inflammatory effectors with HUCB cells could have a protective effect on dying motor neurons. The team had previously shown that hUBC cell transplants reduced inflammation and provided neuroprotection in models of stroke and Alzheimer's disease.

"This preclinical study indicates that MNC hUBC cells may protect motor neurons by inhibiting an immune inflammatory response by decreasing pro-inflammatory cytokines, signaling proteins in the brain and spinal cord that play a role in immu
'/>"/>

Contact: Anne DeLotto Baier
abaier@health.usf.edu
813-974-3300
University of South Florida Health
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cord Blood America Says Pennsylvania Joins New York and California in Informing Parents of the Advantages of Umbilical Cord Blood Storage
2. Health risks, benefits come with delayed umbilical cord clamping
3. Injection of human umbilical cord blood helps the aging brain
4. Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage
5. Umbilical cord clamping should be delayed, says expert
6. Going Online to Draw the Line on High Blood Pressure
7. New blood clot guidelines for pregnant women
8. Local Blood Supply at Low Levels
9. Study in Circulation provides detail on how low blood flow promotes vascular disease
10. Symptom Screening Plus a Simple Blood Test Equals a 20 Percent Jump in Early Detection of Ovarian Cancer
11. Symptoms Plus Blood Test Boost Ovarian Cancer Detection
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology 2Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Amgen to Present at the Thomas Weisel Healthcare Conference 56481 1Amgen to Present at the Thomas Weisel Healthcare Conference 56481 2Antiviral Drugs Should Be Used Cautiously to Fight Flu U S Says 56479 1Antiviral Drugs Should Be Used Cautiously to Fight Flu U S Says 56479 2Antiviral Drugs Should Be Used Cautiously to Fight Flu U S Says 56479 3Caliper Life Sciences to Present at UBS Global Life Sciences Conference 56476 1